Purdue Pharma receives $5.5 billion sentence, paving way for opioid settlement
Airfind news item
Published on April 29, 2026.
Purdue Pharma has been sentenced to $5.5 billion in fines and penalties for its guilty plea to charges of deceiving government regulators and paying kickbacks to doctors to boost opioid sales. The sentence clears the way for the company to dissolve in bankruptcy and use its assets to fund a $7.4 billion settlement intended to compensate people affected by the opioid epidemic. The plea deal allows most of the $5.,000 in fines to go unpaid, with only $225 million as long as Purdue uses its remaining assets to repaying its creditors. The sentencing comes as people harmed by opioids express frustration over the company's long-running bankruptcy process.
Read Original Article